Metaclipse Therapeutics Corporation Email Format

Biotechnology ResearchTexas, United States11-50 Employees

Metaclipse Therapeutics is a clinical stage biotech company developing next-generation immunotherapies to treat cancer & vaccines to prevent infectious diseases using our proprietary biological adjuvants. Our personalized immunotherapy platform, Membrex™, has demonstrated promising preclinical data across multiple solid tumors with Phase 1 clinical trials for triple negative breast cancer (TNBC) and head and neck cancer (HNSCC) underway. We are committed to continuous innovation using biological adjuvants for therapeutic and preventative vaccines.

Sign up for free to view info

Company overview Employee directory